Cargando…

The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus

Systemic Lupus Erythematosus (SLE) is an autoimmune disease resulting in autoantibody production, immune complex deposition, and complement activation. The standard biomarkers such as anti-dsDNA and complements (C3 and C4) do not always correlate with active clinical SLE. The heterogeneity of SLE pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thanadetsuntorn, Chokchai, Ngamjanyaporn, Pintip, Setthaudom, Chavachol, Hodge, Kenneth, Saengpiya, Nisara, Pisitkun, Prapaporn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805742/ https://www.ncbi.nlm.nih.gov/pubmed/29422675 http://dx.doi.org/10.1038/s41598-018-20947-4

Ejemplares similares

The expansion of activated naive DNA autoreactive B cells and its association with disease activity in systemic lupus erythematosus patients
por: Wangriatisak, Kittikorn, et al.
Publicado: (2021)

A Prospective Study of Cytomegalovirus-Specific Cell-Mediated Immune Monitoring and Cytomegalovirus Infection in Patients With Active Systemic Lupus Erythematosus Receiving Immunosuppressants
por: Bruminhent, Jackrapong, et al.
Publicado: (2021)

Efficacy and safety of rituximab biosimilar in refractory lupus
por: Pongtarakulpanit, Nantakarn, et al.
Publicado: (2020)

2684. The Prospective Pilot Study of Infectious Complication Surveillance in Active Systemic Lupus Erythematosus Patients with Intense Immunosuppressive Therapy: Cellular Response and Clinical Outcomes
por: Rotjanapan, Porpon, et al.
Publicado: (2019)

2655. A Prospective Study of Cytomegalovirus Infection in Active Systemic Lupus Erythematosus Patients with Intense Immunosuppressive Therapy: Epidemiology, Associated Risk Factors, Pathogenesis, and Clinical Outcomes
por: Bushyakanist, Asalaysa, et al.
Publicado: (2019)

2222. A study of the role of trimethoprim-sulfamethoxazole in opportunistic infection prevention in lupus patients taking low-level immunosuppressive treatment: An open-labeled, randomized controlled trial
por: Munthananuchat, Paopat, et al.
Publicado: (2023)

Vaginal microbiota affects urinary tract infection risk in women with systemic lupus erythematosus: a pilot cross-sectional study from Thailand
por: Rotjanapan, Porpon, et al.
Publicado: (2021)

1147. A study of high-dose influenza vaccination responses compared to standard-dose in lupus patients: an open- labeled, randomized controlled study
por: Yingyounyong, Sasicha, et al.
Publicado: (2023)

280. A cross-sectional pilot study on the relationship of gut microbiota pattern to immunogenicity of influenza vaccine in lupus patients
por: Kiewsanuan, Nathathai, et al.
Publicado: (2023)

Prospective Pilot Study of Cyclophosphamide as an Adjunct Treatment in Patients With Adult-Onset Immunodeficiency Associated With Anti-interferon-γ Autoantibodies
por: Laisuan, Wannada, et al.
Publicado: (2020)

Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios
por: Ngamjanyaporn, Pintip, et al.
Publicado: (2022)

Performance of cytokine models in predicting SLE activity
por: Ruchakorn, Nopparat, et al.
Publicado: (2019)

Trichoscopic Signs in Dermatomyositis, Systemic Lupus Erythematosus, and Systemic Sclerosis: A Comparative Study of 150 Patients
por: Chanprapaph, Kumutnart, et al.
Publicado: (2022)

Meta-analysis of genome-wide association study identifies FBN2 as a novel locus associated with systemic lupus erythematosus in Thai population
por: Tangtanatakul, Pattarin, et al.
Publicado: (2020)

Correlations between serum interleukin 6, serum soluble interleukin 6 receptor, and disease activity in systemic juvenile idiopathic arthritis patients treated with or without tocilizumab
por: Vilaiyuk, Soamarat, et al.
Publicado: (2019)

Performance of real-time PCR and immunofluorescence assay for diagnosis of Pneumocystis pneumonia in real-world clinical practice
por: Chotiprasitsakul, Darunee, et al.
Publicado: (2020)

Health related quality of life in anti interferon γ autoantibody associated immunodeficiency syndrome measured with EQ5D5L and SF36
por: Temsangsukmanee, Jirat, et al.
Publicado: (2023)

Optimal time for COVID-19 vaccination in rituximab-treated dermatologic patients
por: Seree-aphinan, Chutima, et al.
Publicado: (2023)

CD4(+) T-cell cooperation promoted pathogenic function of activated naïve B cells of patients with SLE
por: Wangriatisak, Kittikorn, et al.
Publicado: (2022)

SARS‐CoV‐2 neutralizing antibodies decline over one year and patients with severe COVID‐19 pneumonia display a unique cytokine profile
por: Vacharathit, Vimvara, et al.
Publicado: (2021)

Lupus-like Disease in FcγRIIB(−/−) Mice Induces Osteopenia
por: Visitchanakun, Peerapat, et al.
Publicado: (2019)

Hypomethylation of interleukin 6 correlates with renal involvement in systemic lupus erythematosus
por: Tang, Chun, et al.
Publicado: (2014)

Relationship between Disease Characteristics and Circulating Interleukin 6 in a Well-Characterized Cohort of Patients with Systemic Lupus Erythematosus
por: Mercader-Salvans, Julia, et al.
Publicado: (2023)

Correlation between circulating interleukin-18 level and systemic lupus erythematosus: a meta-analysis
por: Xiang, Mengmeng, et al.
Publicado: (2021)

Clinical Characteristics of Anti-Synthetase Syndrome and Variables Associated with Interstitial Lung Disease and Mortality: A Retrospective Cohort Study
por: Sodsri, Tulaton, et al.
Publicado: (2023)

cGAS deficiency enhances inflammasome activation in macrophages and inflammatory pathology in pristane-induced lupus
por: Kumpunya, Sarinya, et al.
Publicado: (2022)

Detection by Flow Cytometry of Anti-DNA Autoantibodies and Circulating DNA Immune Complexes in Lupus Erythematosus
por: Abuaf, Nisen, et al.
Publicado: (2019)

False-positive dengue IgM test result in a patient with systemic lupus erythematosus: a case report
por: Kamolratanakul, Supitcha, et al.
Publicado: (2020)

Serum and Urinary Interleukin-6 in Assessment of Renal Activity in Egyptian Patients with Systemic Lupus Erythematosus
por: EL-Shereef, Rawhya R., et al.
Publicado: (2016)

Clinical associations of serum interleukin-17 in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2013)

Low-dose interleukin-2 therapy in systemic lupus erythematosus
por: La Cava, Antonio
Publicado: (2023)

Cutaneous and Extracutaneous Manifestations of Behçet’s Disease Linked to Its Disease Activity and Prognosis
por: Limtong, Preeyachat, et al.
Publicado: (2020)

Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus
Publicado: (1979)

Serum interleukin-6 level is correlated with the disease activity of systemic lupus erythematosus: a meta-analysis
por: Ding, Jianwen, et al.
Publicado: (2020)

Interleukin-21: A New Mediator of Inflammation in Systemic Lupus Erythematosus
por: Sarra, Massimiliano, et al.
Publicado: (2010)

Serum Interleukin-34 Levels Are Elevated in Patients with Systemic Lupus Erythematosus
por: Wang, Hongxu, et al.
Publicado: (2016)

T Cells, Interleukin-2 and Systemic Lupus Erythematosus—From Pathophysiology to Therapy
por: Mak, Anselm
Publicado: (2022)

Quality of gout care in the emergency departments: a multicentre study
por: Towiwat, Patapong, et al.
Publicado: (2020)

Etanercept prevents TNF-α mediated mandibular bone loss in FcγRIIb(-/-) lupus model
por: Sakunrangsit, Nithidol, et al.
Publicado: (2021)

SYSTEMIC LUPUS ERYTHEMATOSUS: PROTOTYPE OF IMMUNE COMPLEX NEPHRITIS IN MAN
por: Koffler, D., et al.
Publicado: (1971)

Cannot write session to /tmp/vufind_sessions/sess_3b77fn346idjek3jolhqting4v